Antigen-induced XXXX in @entity95 : a comparative study between high-resolution ultrasound and contrast-enhanced ultrasound and pathologic findings.

@entity95 @entity625 @entity603
The objective of this study was to explore the feasibility and value of high-resolution ultrasound and contrast-enhanced ultrasound in evaluation of @entity603 in @entity95 knee joint in @entity625 ( @entity625 ). Thirty-six @entity95 were divided into three groups, each injected with different doses of ovalbumin (OVA) into the right knee joint. On week 1 and 4, 6 randomly selected in each group were killed. Each knee joint undergone the high-resolution ultrasound to measure capsule thickness and contrast-enhanced ultrasound to measure synovium thickness. The results from the ultrasound examinations were compared with those of pathologic examinations. Different OVA doses resulted in different modeling success rate, different pathological @entity603 score, and different capsule and synovium thickness measured by ultrasound. The diagnostic accuracy of @entity603 by ultrasound was high. The ultrasound measurement revealed that the capsule thickness on week 4 was lessened than that on week 1, while the synovial thickness on week 4 was greater than that on week 1. Both the joint capsule and synovium thickness measured by ultrasound were significantly and positively correlated to the pathologic @entity603 score (P  <  0.05). The synovial thickness on week 4 is more correlated to the @entity603 score than the capsule thickness, rather than that on week 1. Injection of OVA of different doses results in different modeling success rate and @entity603 severity. The high-resolution ultrasound and contrast-enhanced ultrasound can be used to determine whether the @entity625 was made successfully and evaluate the @entity603 severity. In chronic inflammatory phase, the contrast-enhanced ultrasound has better effect.
